Omeros Corporation (OMER) Financials

OMER Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 286.2 million 349.5 million
Dec. 31, 2025 325.6 million 446.9 million
Sept. 30, 2025 185.7 million 406.2 million
June 30, 2025 200.6 million 429.3 million

OMER Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -14.5 million 1.9 million
Dec. 31, 2025 -39.8 million 1.7 million
Sept. 30, 2025 -18.5 million 1.9 million
June 30, 2025 -22.0 million 2.1 million

OMER Net Income

No data available :(

OMER Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 135.3 million 278.8 million 5.6 million
Dec. 31, 2025 171.8 million 208.5 million 13.5 million
Sept. 30, 2025 36.1 million 159.6 million 15.0 million
June 30, 2025 28.7 million 150.8 million 16.5 million

OMER Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 63.5 million
Dec. 31, 2025 63.5 million
Sept. 30, 2025 66.3 million
June 30, 2025 58.6 million

OMER Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 13.1 million 13.4 million -
Dec. 31, 2025 - 19.4 million 9.6 million -
Sept. 30, 2025 11000 16.0 million 10.4 million -
June 30, 2025 13000 22.0 million 10.3 million -

OMER Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 9.9 million 826000
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - 10.3 million

OMER

Price: $10.16

52 week price:
2.95
17.65

Earnings Per Share: 1.14 USD

P/E Ratio: 10.26

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 328300

Ebitda: -4.6 million

Market Capitalization: 846.8 million

Links: